GLASGOW, Scotland, July 19 (GenomeWeb News) - Nyrion, a gene knockdown and expression-analysis shop, has been accredited by GE Healthcare to offer CodeLink microarrays as part of an expression-analysis service, officials from both companies confirmed today.
Peter Estibeiro, managing director of the
Estibeiro spoke with GenomeWeb News at the BioScience 2005 conference, held here this week.
Penny Owen, a GE Healthcare marketing director, confirmed the deal had closed in recent weeks. An official announcement from both parties is pending, according to Estibeiro.
In addition to the CodeLink offering, Nyrion sells antisense and siRNA reagents on its AccessArray 4000 system, as well as other reagents, according to the company's commercial literature.